Spectropharma is a Saudi company that was established in 2019. It's core business is development, manufacturing, and sales of pharmaceutical products in Saudi Arabia and abroad. Spectropharma manufacturing facility is in Sudair industrial city, 120KM north east of Riyadh, with a plant site that covers 54,000 sq. m. The plant was constructed and equipped up to the highest quality levels. Spectropharma believes that quality is the most vital determinant of a company's reputation among commercial and institutional customers in the pharmaceutical industry. Therefore, emphasis on high quality is the seesnce of its brands and will help company to differentiate from the market along with affordable medicine prices to its patients. Through a robust quality standard, state of the art technologies, and high talent pharmacist, enginers and marketers, Spectropharma would leverage its strengths to establish itself as a major player in the pharmaceutical market in KSA and across the globe. Spectropharma specializes in producing Biosimilars, generic pharmaceuticals, CSSD, and infection protection products through partnership with multinational companies as well as in-house development. Spectropharma will forge strategic relationships, alliances, and partnerships with channel partners to maximize its reach and prevention.